home / stock / cnsp / cnsp quote
Last: | $ |
---|---|
Change Percent: | 0.24% |
Open: | $4.15 |
Close: | $4.11 |
High: | $4.2986 |
Low: | $4.10 |
Volume: | 44,730 |
Last Trade Date Time: | 02/12/2020 04:44:03 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $4.15 | $4.11 | $4.2986 | $4.10 | 44,730 | 02-12-2020 |
$ | $4.29 | $4.10 | $4.30 | $4.08 | 34,604 | 02-11-2020 |
$ | $4.17 | $4.06 | $4.20 | $4.06 | 51,642 | 02-10-2020 |
$ | $4.33 | $4.27 | $4.45 | $4.2009 | 46,271 | 02-07-2020 |
$ | $4.44 | $4.37 | $4.563 | $4.31 | 28,828 | 02-06-2020 |
$ | $4.71 | $4.44 | $4.71 | $4.37 | 42,014 | 02-05-2020 |
$ | $4.35 | $4.60 | $4.75 | $4.35 | 111,600 | 02-04-2020 |
$ | $4.32 | $4.36 | $4.40 | $4.28 | 33,278 | 02-03-2020 |
$ | $4.37 | $4.31 | $4.37 | $4.252 | 36,932 | 01-31-2020 |
$ | $4.18 | $4.35 | $4.3599 | $4.12 | 107,353 | 01-30-2020 |
$ | $4.27 | $4.12 | $4.30 | $4.09 | 43,414 | 01-29-2020 |
$ | $4.30 | $4.23 | $4.38 | $4.16 | 66,638 | 01-28-2020 |
$ | $4.39 | $4.32 | $4.40 | $4.24 | 70,676 | 01-27-2020 |
$ | $4.46 | $4.40 | $4.50 | $4.39 | 33,931 | 01-24-2020 |
$ | $4.45 | $4.45 | $4.50 | $4.3927 | 71,859 | 01-23-2020 |
$ | $4.46 | $4.3936 | $4.4676 | $4.33 | 54,803 | 01-22-2020 |
$ | $4.38 | $4.48 | $4.49 | $4.3501 | 63,665 | 01-21-2020 |
$ | $4.49 | $4.33 | $4.49 | $4.25 | 46,317 | 01-20-2020 |
$ | $4.49 | $4.33 | $4.49 | $4.25 | 46,317 | 01-17-2020 |
$ | $4.40 | $4.46 | $4.55 | $4.39 | 60,069 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
Presentation on Monday, April 29 th at 4:15 PM (GMT+1) HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the ...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured on the Virtual Investor Lunch Break: The CNSP Opportunity event. During the l...
Live video webcast with Chief Executive Officer, John Climaco, on Tuesday, April 23 rd at 12:00 PM ET HOUSTON, TX / ACCESSWIRE / April 22, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatm...